ONK THERAPEUTICS

onk-therapeutics-logo

ONK Therapeutics is an innovative cell therapy company dedicated to developing the next generation of off-the-shelf, optimally engineered natural killer (NK) cell therapies targeting both hematological malignancies and solid tumors.

#SimilarOrganizations #People #Financial #Event #Website #More

ONK THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Therapeutics

Founded:
2009-01-01

Address:
Barna, Galway, Ireland

Country:
Ireland

Website Url:
http://www.onktherapeutics.com

Total Employee:
11+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
21.5 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Euro Contact Form 7 WordPress 5.9 LinkedIn Follow Company Plugin


Similar Organizations

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

atara-biotherapeutics-logo

Atara Biotherapeutics

Atara Biotherapeutics (Nasdaq: ATRA) is an off-the-shelf, allogeneic T-cell immunotherapy company.

vyne-therapeutics-logo

VYNE Therapeutics

VYNE Therapeutics developing proprietary, innovative and differentiated therapies in dermatology and beyond.


Current Advisors List

not_available_image

Andrew Phillips Board Member @ ONK Therapeutics
Board_member
2022-01-01

Current Employees Featured

michael-odwyer_image

Michael O&s;Dwyer
Michael O'Dwyer Founder and CSO @ ONK Therapeutics
Founder and CSO

tony-killarney_image

Tony Killarney
Tony Killarney Founder & Director @ ONK Therapeutics
Founder & Director
2015-07-01

chris-nowers_image

Chris Nowers
Chris Nowers Chief Executive Officer @ ONK Therapeutics
Chief Executive Officer
2020-10-01

Founder


michael-odwyer_image

Michael O'Dwyer

tony-killarney_image

Tony Killarney

Investors List

cormorant-asset-management_image

Cormorant Asset Management

Cormorant Asset Management investment in Series A - ONK Therapeutics

acorn-bioventures_image

Acorn Bioventures

Acorn Bioventures investment in Series A - ONK Therapeutics

alshc_image

ALSHC

ALSHC investment in Series A - ONK Therapeutics

Key Employee Changes

Date New article
2021-09-03 XNK Therapeutics appoints Markus Thor as Chief Business Officer

Official Site Inspections

http://www.onktherapeutics.com Semrush global rank: 4.76 M Semrush visits lastest month: 1.94 K

  • Host name: pemlinng060.blacknight.com
  • IP address: 78.153.210.6
  • Location: Ireland
  • Latitude: 53.3472
  • Longitude: -6.2439
  • Timezone: Europe/Dublin

Loading ...

More informations about "ONK Therapeutics" on Search Engine